探索性分析:POLE外切酶结构域突变子宫内膜癌中驱动基因变异及其潜在预后相关性
本研究分析马偕纪念医院2014年2月至2017年2月100例子宫内膜癌组织样本,采用Illumina MiSeq平台测序。POLE外切酶结构域突变(POLEmut)肿瘤突变负荷显著更高(p<0.0001),总生存优于POLE野生型(POLEwt,p<0.0388;HR:3.624)。POLEmut中抑癌基因TP53、PIK3R1、FBXW7突变(均p<0.01)与更好生存相关(HR:3.929-6.598,均p<0.05)。
要点
- POLEmut肿瘤突变负荷显著高于POLEwt(p<0.0001)。
- POLEmut患者总生存优于POLEwt(p<0.0388;HR:3.624)。
- POLEmut中TP53、PIK3R1、FBXW7突变与更好生存相关(HR:3.929-6.598,均p<0.05)。
核心结论
- 本探索性研究发现POLE外切酶结构域突变与抑癌基因和癌基因间不同的突变模式相关,为POLEmut肿瘤良好预后的潜在机制提供假设生成性见解。
研究设计与样本
- 回顾性分析马偕纪念医院2014年2月至2017年2月100例子宫内膜癌组织样本,采用Illumina MiSeq平台测序及QIAGEN CLC Workbench分析,统计采用Kaplan-Meier分析和Fisher精确检验。
主要发现
- POLE突变主要位于外切酶结构域,共鉴定36个错义变异,其中19个位于该特定结构域。
- POLEmut肿瘤突变负荷显著高于POLEwt(p<0.0001)。
- Kaplan-Meier分析显示POLEmut患者总生存优于POLEwt(p<0.0388;HR:3.624)。
- POLEmut病例中抑癌基因TP53、PIK3R1、FBXW7突变呈散在分布且无义突变率更高(均p<0.01),与癌基因PIK3CA、CTNNB1、KRAS形成对比。
- POLEmut病例中TP53、PIK3R1、FBXW7突变者生存显著优于携带相同基因突变的POLEwt病例(HR:3.929-6.598,均p<0.05)。
临床怎么用
- 原文未据此给出推荐,仅指出这些观察为假设生成性见解,可能为未来子宫内膜癌分子研究提供信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endometrial cancer represents a significant gynecologic malignancy affecting women globally, including Taiwan. This study aimed to analyze mutation patterns in endometrial cancer genes related to POLE exonuclease domain mutations and their association with patient prognosis. METHODS: We analyzed 100 endometrial cancer tissue samples from patients at MacKay Memorial Hospital (February 2014-February 2017). DNA sequencing was conducted on an Illumina MiSeq platform with subsequent QIAGEN CLC Workbench analysis. We applied Kaplan-Meier analysis and Fisher's exact test for statistical evaluations. RESULTS: Mutations in POLE were primarily located in the exonuclease domain, with 36 missense variants identified, of which 19 were in this specific domain. Tumors with POLE exonuclease domain mutations (POLEmut) exhibited a significantly higher tumor mutation burden (p < 0.0001), and Kaplan-Meier analysis revealed better overall survival for patients with POLEmut tumors compared to POLE wild-type tumors (POLEwt, p < 0.0388; HR: 3.624). In POLEmut cases, tumor suppressor genes showed scattered mutations with higher nonsense rates (TP53, PIK3R1, FBXW7; all p < 0.01), contrasting with oncogenes (PIK3CA, CTNNB1, KRAS). Mutations in tumor suppressor genes (TP53, PIK3R1, FBXW7) conferred significantly better survival outcomes in POLEmut cases compared to their POLEwt counterparts with identical gene mutations (HR: 3.929-6.598, all p < 0.05). CONCLUSION: This exploratory study finds that POLE exonuclease domain mutations are associated with distinct mutational patterns that vary between tumor suppressor genes and oncogenes. These observations provide hypothesis-generating insights into potential mechanisms underlying the favorable prognosis of POLEmut tumors and may inform future molecular investigations in endometrial cancer.
引用
- Wei TY, Wu CC, Hsu YT, et al. An exploratory analysis of driver gene alterations and their potential prognostic relevance in endometrial cancer with POLE exonuclease domain mutations. Gynecol Oncol. 2025. PMID: 40516204. doi:10.1016/j.ygyno.2025.06.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。